Sage Journals: Discover world-class research

Abstract

Recent research suggests that hyperhomo-cysteinemia is a significant risk factor for thrombosis. The mechanism for this is not completely understood. However, studies have shown that high intakes of folic acid, vitamin B¹², and vitamin B⁶ can lower homocysteine levels. This case study describes a patient with a 7-year history of postprandial pain who was diagnosed with mesenteric ischemia. She was found to have moderate hyperhomocysteinemia and was subsequently treated with B vitamins. Unable to tolerate enteral nutrition, the patient was maintained on- parenteral nutrition before surgery. After resection of ischemic, strictured gut, her parenteral nutrition was discontinued and she gained weight on an oral diet. Her serum homocysteine level dropped to low-normal, therefore, vitamin B supplementation continues. Since surgery, the patient has been without symptoms of chronic ischemia.

Get full access to this article

View all access options for this article.

References

1. Jung MT , Jacobs DL : Unusual causes of mesenteric ischemia. IN Intestinal Ischemia Disorders: Pathophysiology and Management, Longo WE , Peterson GJ , Jacobs DL (Eds.) Quality Medical Publishing, Inc., St. Louis, 1998, pp 243–258

2. McQuillan BM , Beilby JP , Nidorf M , et al: Hyperhomocysteine-mia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. Circulation 99:2383–2388, 1999

3. Den Heijer M , Rosendaal FR , Blom HJ , et al: Hyperhomocysteine-mia and venous thrombosis: A meta-analysis. Thromb Haemost 80:874–877, 1998

4. DcJong SC , Stehouwer CD , van den Berg M , et al: Normohomo-cysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events patients with premature peripheral arterial occlusive disease. A prospective cohort study. J Intern Med 246(1):87–96, 1999

5. Taylor LM , Moneta GL , Sexton GJ , et al: Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vase Surg 29:8–21, 1999

6. Heijer MD , Koster T , Blom HJ , et al: Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334:759–762, 1996

7. House AA , Donnelly JG : Effect of multivitamins on plasma homocysteine and folate levels in patients on hemodialysis. ASAIO J 45:94–97, 1999

8. Siri PW , Verhoef P , Kok FJ : Vitamins B6, B12, and folate: Association with plasma total homocysteine and risk of coronary atherosclerosis. J Am Coll Nutr 17(5):435–441, 1998

9. Bakker RC , Brandjes DP , Snel P , et al: Malabsorption syndrome associated with ulceration of the stomach and small bowel caused by chronic intestinal ischemia in a patient with hyperhomocysteinemia. Mayo Clin Proc 72(6):546–550, 1997

10.

10. Boers GH , Smals AG , Trijbels FJ , et al: Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 313:709–715, 1985

11.

11. Stanley JC : Chronic mesenteric ischemia. IN Intestinal Ischemia Disorders: Pathophysiology and Management, Longo WE , Peterson GJ , Jacobs DL (Eds.) Quality Medical Publishing, Inc., St. Louis, 1998, pp 189–205

12.

12. OASIS Home Nutrition Support Patient Registry Annual Reports. 1985–1992. The Oley Foundation, Albany, NY, 1985–1994

13.

13. Guba SC , Fonseca V , Fink LM : Hyperhomocysteinemia and thrombosis. Semin Thromb Hemost 25(3):291–304, 1999

14.

14. Hankey GJ , Eikelboom JW : Homocysteine and vascular disease. Lancet 354:407–413, 1999

15.

15. Welch GN , Loscalzo J : Mechanism of disease: Homocysteine and atherothrombosis. N Engl J Med 338(15): 1042–1050, 1998

16.

16. Malinow RM , Bostom AG , Krauss RM : Homocysteine, diet, and cardiovascular diseases. A statement for healthcare professionals from the nutrition committee, American Heart Association. Circulation 99:178–182, 1999

17.

17. Herrmann W , Quast S , Ullrich M , et al. Hyperhomocysteinemia in high-aged subjects: Relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation. Atherosclerosis 144:91–101, 1999

18.

18. Moustapha A , Robinson K : Homocysteine: An emerging age-related cardiovascular risk factor. Geriatrics 54(4):41–51, 1999

Use of B Vitamins to Reduce Homocysteine in Chronic Mesenteric Ischemia

Abstract

Get full access to this article

References